| Application no. and date | 16718835.8 (espacenet) (Federated) (European Patent Register), 20160415 | | Patent/reg. no. and date | DK/EP 3283107, 20200527 | | Publication date | 20180221 | | Priority no. and date | US 201562149325 P, 20150417, US 201562265268 P, 20151209, US 201562269000 P, 20151217, US 201662303855 P, 20160304 | | EP pub. no. and date |
EP 3283107 20180221 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V155019DK | | Inventor | SADINENI, Vikram, Rt. 206&Province Line Road
Princeton, New Jersey 08543, US,
QUAN, Yong, Rt. 206&Province Line Road
Princeton, New Jersey 08543, US,
KASERER, Wallace, 9 Vaccaro Road
Lawrence Township, New Jersey 08648, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | SAMMENSÆTNINGER OMFATTENDE EN KOMBINATION AF IPILIMUMAB OG NIVOLUMAB | | Int. application no. | US2016027913 | | Int. publication no. | WO2016168716 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
